The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transarterial Radioembolization (TARE)-Global Market Insights and Sales Trends 2025
Synopsis
The global Transarterial Radioembolization (TARE) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Transarterial Radioembolization (TARE) in various end use industries. The expanding demands from the Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, are propelling Transarterial Radioembolization (TARE) market. Microspheres, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Particles segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Transarterial Radioembolization (TARE) market, driven by demand from China, the second largest economy with some signs of stabilising, the Transarterial Radioembolization (TARE) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transarterial Radioembolization (TARE), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transarterial Radioembolization (TARE) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transarterial Radioembolization (TARE) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transarterial Radioembolization (TARE) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transarterial Radioembolization (TARE) covered in this report include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation and HENGRUI Medical, etc.
The global Transarterial Radioembolization (TARE) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
Global Transarterial Radioembolization (TARE) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transarterial Radioembolization (TARE) market, Segment by Type:
Microspheres
Particles
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres
Global Transarterial Radioembolization (TARE) market, by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transarterial Radioembolization (TARE) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Transarterial Radioembolization (TARE) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Transarterial Radioembolization (TARE) in various end use industries. The expanding demands from the Uterine Fibroid Embolization, Prostatic Artery Embolization, Liver Tumor Embolization and Trauma Embolization, are propelling Transarterial Radioembolization (TARE) market. Microspheres, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Particles segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Transarterial Radioembolization (TARE) market, driven by demand from China, the second largest economy with some signs of stabilising, the Transarterial Radioembolization (TARE) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transarterial Radioembolization (TARE), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transarterial Radioembolization (TARE) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transarterial Radioembolization (TARE) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transarterial Radioembolization (TARE) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transarterial Radioembolization (TARE) covered in this report include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation and HENGRUI Medical, etc.
The global Transarterial Radioembolization (TARE) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
Global Transarterial Radioembolization (TARE) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transarterial Radioembolization (TARE) market, Segment by Type:
Microspheres
Particles
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres
Global Transarterial Radioembolization (TARE) market, by Application
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transarterial Radioembolization (TARE) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Transarterial Radioembolization (TARE)
1.1 Transarterial Radioembolization (TARE) Market Overview
1.1.1 Transarterial Radioembolization (TARE) Product Scope
1.1.2 Transarterial Radioembolization (TARE) Market Status and Outlook
1.2 Global Transarterial Radioembolization (TARE) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Transarterial Radioembolization (TARE) Market Size by Region (2018-2029)
1.4 Global Transarterial Radioembolization (TARE) Historic Market Size by Region (2018-2023)
1.5 Global Transarterial Radioembolization (TARE) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Transarterial Radioembolization (TARE) Market Size (2018-2029)
1.6.1 North America Transarterial Radioembolization (TARE) Market Size (2018-2029)
1.6.2 Europe Transarterial Radioembolization (TARE) Market Size (2018-2029)
1.6.3 Asia-Pacific Transarterial Radioembolization (TARE) Market Size (2018-2029)
1.6.4 Latin America Transarterial Radioembolization (TARE) Market Size (2018-2029)
1.6.5 Middle East & Africa Transarterial Radioembolization (TARE) Market Size (2018-2029)
2 Transarterial Radioembolization (TARE) Market by Type
2.1 Introduction
2.1.1 Microspheres
2.1.2 Particles
2.1.3 Drug-eluting Beads (DEBs)
2.1.4 Radio-Embolic Microspheres
2.2 Global Transarterial Radioembolization (TARE) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Type (2018-2023)
2.2.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Transarterial Radioembolization (TARE) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Transarterial Radioembolization (TARE) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Transarterial Radioembolization (TARE) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Transarterial Radioembolization (TARE) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Transarterial Radioembolization (TARE) Revenue Breakdown by Type (2018-2029)
3 Transarterial Radioembolization (TARE) Market Overview by Application
3.1 Introduction
3.1.1 Uterine Fibroid Embolization
3.1.2 Prostatic Artery Embolization
3.1.3 Liver Tumor Embolization
3.1.4 Trauma Embolization
3.1.5 Others
3.2 Global Transarterial Radioembolization (TARE) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Transarterial Radioembolization (TARE) Historic Market Size by Application (2018-2023)
3.2.2 Global Transarterial Radioembolization (TARE) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Transarterial Radioembolization (TARE) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Transarterial Radioembolization (TARE) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Transarterial Radioembolization (TARE) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Transarterial Radioembolization (TARE) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Transarterial Radioembolization (TARE) Revenue Breakdown by Application (2018-2029)
4 Transarterial Radioembolization (TARE) Competition Analysis by Players
4.1 Global Transarterial Radioembolization (TARE) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transarterial Radioembolization (TARE) as of 2022)
4.3 Date of Key Players Enter into Transarterial Radioembolization (TARE) Market
4.4 Global Top Players Transarterial Radioembolization (TARE) Headquarters and Area Served
4.5 Key Players Transarterial Radioembolization (TARE) Product Solution and Service
4.6 Competitive Status
4.6.1 Transarterial Radioembolization (TARE) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sirtex Medical
5.1.1 Sirtex Medical Profile
5.1.2 Sirtex Medical Main Business
5.1.3 Sirtex Medical Transarterial Radioembolization (TARE) Products, Services and Solutions
5.1.4 Sirtex Medical Transarterial Radioembolization (TARE) Revenue (US$ Million) & (2018-2023)
5.1.5 Sirtex Medical Recent Developments
5.2 Merit Medical
5.2.1 Merit Medical Profile
5.2.2 Merit Medical Main Business
5.2.3 Merit Medical Transarterial Radioembolization (TARE) Products, Services and Solutions
5.2.4 Merit Medical Transarterial Radioembolization (TARE) Revenue (US$ Million) & (2018-2023)
5.2.5 Merit Medical Recent Developments
5.3 Cook Medical
5.3.1 Cook Medical Profile
5.3.2 Cook Medical Main Business
5.3.3 Cook Medical Transarterial Radioembolization (TARE) Products, Services and Solutions
5.3.4 Cook Medical Transarterial Radioembolization (TARE) Revenue (US$ Million) & (2018-2023)
5.3.5 BTG Medical Recent Developments
5.4 BTG Medical
5.4.1 BTG Medical Profile
5.4.2 BTG Medical Main Business
5.4.3 BTG Medical Transarterial Radioembolization (TARE) Products, Services and Solutions
5.4.4 BTG Medical Transarterial Radioembolization (TARE) Revenue (US$ Million) & (2018-2023)
5.4.5 BTG Medical Recent Developments
5.5 Boston Scientific Corporation
5.5.1 Boston Scientific Corporation Profile
5.5.2 Boston Scientific Corporation Main Business
5.5.3 Boston Scientific Corporation Transarterial Radioembolization (TARE) Products, Services and Solutions
5.5.4 Boston Scientific Corporation Transarterial Radioembolization (TARE) Revenue (US$ Million) & (2018-2023)
5.5.5 Boston Scientific Corporation Recent Developments
5.6 Terumo Corporation
5.6.1 Terumo Corporation Profile
5.6.2 Terumo Corporation Main Business
5.6.3 Terumo Corporation Transarterial Radioembolization (TARE) Products, Services and Solutions
5.6.4 Terumo Corporation Transarterial Radioembolization (TARE) Revenue (US$ Million) & (2018-2023)
5.6.5 Terumo Corporation Recent Developments
5.7 HENGRUI Medical
5.7.1 HENGRUI Medical Profile
5.7.2 HENGRUI Medical Main Business
5.7.3 HENGRUI Medical Transarterial Radioembolization (TARE) Products, Services and Solutions
5.7.4 HENGRUI Medical Transarterial Radioembolization (TARE) Revenue (US$ Million) & (2018-2023)
5.7.5 HENGRUI Medical Recent Developments
6 North America
6.1 North America Transarterial Radioembolization (TARE) Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Transarterial Radioembolization (TARE) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transarterial Radioembolization (TARE) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transarterial Radioembolization (TARE) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transarterial Radioembolization (TARE) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transarterial Radioembolization (TARE) Market Dynamics
11.1 Transarterial Radioembolization (TARE) Industry Trends
11.2 Transarterial Radioembolization (TARE) Market Drivers
11.3 Transarterial Radioembolization (TARE) Market Challenges
11.4 Transarterial Radioembolization (TARE) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
